Using a small molecule microarray, we found a selective MYC-G4 binding drug with a benzofuran scaffold (D089) that not only inhibited MYC expression in myeloma cell lines, but also selectively induced G1 arrest in MYC-driven cancer cell lines containing the MYC-G4 sequence. This evidence concerns the gene MYC and plasma cell myeloma.